Posts by Admin BioAlps

GeNeuro secures investment to further clinical trials   GeNeuro, the Geneva-based biopharmaceutical company, announced on 31 January 2020 the securing of a €17.5 international private placement. This investment will support the company in competing its clinical trial of temelimab in multiple sclerosis patients, as well as advance the preclinical programme for ALS and more. Read…

Endotelix Diagnostics Sàrl | Solution provider for Antiphospholipid Syndrome   In 2020, VentureKick allocated CHF 5 million to 80 Swiss startup projects.   The University of Geneva spin-off, Endotelix Diagnostics, which specialises in point-of-care diagnostics for autoimmune diseases, won the Stage 3 prize of CHF 150’000.   Antiphospholipid Syndrome (APS) is one of the main causes of strokes in…

Merck Biotech Development Center | New Facility in Switzerland   On 27 January 2020, Merck announced a €250 million investment to build a new research and manufacturing facility in Corsier-sur-Vevey, in the canton of Vaud.   The investment, to be made between 2019 and 2022, will help secure the needed facility to develop the biotech…

Another milestone for Nanolive, as the company moves to new offices   In 2013, Nanolive started its adventure in a small office space. In 2020, the company will set up its new 1’100 m2 quarters in Tolochenaz.   The Grand Opening will take place on Friday 14th February as of 4:30PM.   You can take part…

Join SILAB and take part in Innosuisse’s NTN Innovation Booster programme Imagine and develop the healthcare of tomorrow   Innovation to tackle healthcare challenges Innovation in healthcare is key to tackle the challenges faced by the healthcare system in a deeply changing societal landscape.It becomes increasingly recognized that innovation must be centred around the patient…

qmt | The industry’s quality test and control reference   On 9 January 2020, SAPHIR and Qualimatest announced that their organisations were merging under a new identity: qmt.   After 30 years of developing a large panel of quality test and control solutions and products for industrial partners; the French and Swiss companies have decided…

Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria. The partnership aims to introduce vanguard AI diagnostic capabilities and improve detection of 75 pathologies, including tuberculosis, to one of the largest markets in Africa.

Leading genomics solutions, combined with advanced analytics, provide benefits to hospitals and patients

Rue du Centre 172

Brain-Computer Interface Technologies | Accelerating Neuro-Technology for Human Benefit The BioAlps team is proud to present our President’s new book. Learn more about brain-computer interfaces and more specifically the use of active implants. Book Abstract “This book is about the field of brain-computer interfaces (BCI) and the unique and special environment of active implants that…